FTIH of ECC5004 in Healthy and Diabetic Participants

FTIH of ECC5004 in Healthy and Diabetic Participants

Placebo Comparator: SAD Cohorts 1 to 2: Participants receiving Placebo
Participants in each SAD cohort will be randomized to receive placebo.
Drug: Placebo
Matching Placebo will be administered as oral tablet. Matching Placebo will be given orally during each dosing day.

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 22, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments